DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,760.00
-80.00 (-1.37%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| Medicine | 247.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Growth | 15.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing Agency | 3.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Marketing Agency Growth | 41.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finance | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finance Growth | 121.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidation Adjustment | -3.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidation Adjustment Growth | 48.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
| South Korea | 249.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 15.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|